vialaudit
sermorelin · pennsylvania

Is Sermorelin legal in Pennsylvania?

status · caveats apply
FDA NDA withdrawn 2009 for commercial (not safety) reasons; still compounded under §503A; WADA S2.2 explicitly named GHRH analogue. No state-level peptide restrictions beyond federal law in Pennsylvania.

category: withdrawn · last verified May 13, 2026

§ 01

Quick answer

FDA NDA withdrawn 2009 for commercial (not safety) reasons; still compounded under §503A; WADA S2.2 explicitly named GHRH analogue. No state-level peptide restrictions beyond federal law in Pennsylvania.
§ 02

Full status breakdown

Federal status

FDA approval
withdrawn · brand: Geref, Geref Diagnostic · NDA 019863; NDA 020443
Indications: historical: diagnostic for GH deficiency; idiopathic GH deficiency in children
DEA scheduling
not scheduled
503A compounding
Bulks list: not on list
Do-not-compound list: not on list
Has been compounded under §503A for years using bulk substances. On Category 1 (eligible for compounding pending review) per 2015 nominations. Federal Register 78 FR 14130 (Mar 4, 2013) confirmed withdrawal was not for safety/effectiveness reasons.
FDA Warning Letters
  • Jan 26, 2022Innoveix Pharmaceuticals Inc. (cited: sermorelin, ipamorelin, aod-9604) · letter
Shortage status
not currently on shortage list
Sale framing
Research-use-only posture: Sits in an unusual posture — previously approved, withdrawn for commercial reasons, still compoundable. Vendors marketing for human use without prescription violate FDCA.
Personal possession: Not federally criminalized.

Pennsylvania — state-specific

Sport-body status

WADA 2026
on prohibited list · class S2.2 · both
Explicitly named under S2.2 (Peptide Hormones — GHRH and analogues) alongside CJC-1293, CJC-1295, tesamorelin.
USADA
NCAA

What we couldn’t verify

§ 03

Also known as

Sermorelin is also marketed or referenced under the following names (vendor pseudonyms, brand names, chemical identifiers):

  • Geref
  • Geref Diagnostic
  • GRF 1-29
  • Mod GRF 1-29 (no DAC analog)
  • Sermorelin acetate
§ 04

Disclaimer

§ 05

Related

the roundup · monthly

Receipts in your inbox. Once a month.

New audits, expired coupons pruned, lab notes from vials still on the bench. No marketing. No lifestyle copy. Unsubscribe in one click.

14,200 subscribers· 0 sponsored items· 11 issues since launch